Exploratory Clinical Development World Europe is right around the corner. We’ve just completed a great agenda bringing together leading industry thought leaders. These individuals will give important insight into how exploratory development is adapting in an era of increasingly targeted, personalised, advanced and combination therapies. Join the discussions around new approaches to de-risk candidate selection and accelerate the next generation of translational research and early clinical development.
Here’s 5 reasons you should attend:
Learn how to accelerate early clinical development with effective study design for candidate progression
Develop successful strategies to bridge the translational gap
Explore new approaches to cardiac safety in early phases of development
Discover how to reduce toxicology related attrition
Share experiences, insights and strategies in interactive peer-to-peer roundtables, case studies and panel discussions
Don’t miss out on this chance to learn from leading pharma companies across Europe discussing translational medicine and early clinical development.
Here’s 5 reasons you should attend:
Learn how to accelerate early clinical development with effective study design for candidate progression
Develop successful strategies to bridge the translational gap
Explore new approaches to cardiac safety in early phases of development
Discover how to reduce toxicology related attrition
Share experiences, insights and strategies in interactive peer-to-peer roundtables, case studies and panel discussions
Don’t miss out on this chance to learn from leading pharma companies across Europe discussing translational medicine and early clinical development.
